Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990, and has now developed into a national key high-tech enterprise and one of the top 100 pharmaceutical enterprises in China. In July 2004, it was successfully listed on Shenzhen Stock Exchange.
The company has a registered capital of 725 million yuan, total assets of 5.3 billion yuan, and now has more than 2,900 employees, including more than 230 doctors. The company has two headquarters in Xinchang and Hangzhou. There are preparation production bases in Xinchang, bulk drug production bases in Shangyu, Jiangxi, and traditional Chinese medicine production bases in Bayannaoer, Inner Mongolia.
At the same time, there are medical device production bases and Yunnan Chinese medicine raw material bases in Shenzhen and Shenyang, and Shanghai R&D Center has been established in Shanghai Zhangjiang Hi-tech Park. Invest and cooperate in the United States, Britain, Israel, South Korea and other countries to establish companies and R&D laboratories.
company profile
The company first engaged in the production and sales of quinolones. After years of accumulation, a pharmaceutical industry layout has been formed, which mainly focuses on preparations in cardiovascular, digestive and spiritual fields, supplemented by quinolones and characteristic raw materials. Through the acquisition of Jufeng, we cut into the field of medical devices and defined the strategic direction of "drugs+devices".
The controlling shareholder and actual controller of the Company is Mr. Lv Gang, who directly and indirectly holds 28.3% of the shares of the Company. Its main subsidiaries are Shangyu Jingxin, Shangrao Jingxin, Inner Mongolia Jingxin and Jufeng Display.
Reference to the above content: Baidu Encyclopedia-Jingxin Pharmaceutical